NFE2L2 and melanoma: Immunohistochemical expression of NRF3 was then studied in a sample set of benign and dysplastic naevi, melanomas, and their lymph node metastases showing that similar to NRF2 and NRF1 [17], NRF3 was also downregulated during melanoma carcinogenesis at the protein level.